All News

All news in Politics, Science, Sports, Technology, World, Gaming/Video Games and Business

All news is a category which encapsulates all categories of news on WeeklyReviewer

Lyra Therapeutics Announces Additional Data Presentations from Phase 2 LANTERN Study at the American Rhinologic Society Annual Meeting

Significantly more patients with moderate/severe symptoms of chronic rhinosinusitis at baseline improved to mild/no symptoms at week 24 after treatment with LYR-210 (7500μg) compared...

Disney100: The Exhibition to Immerse Guests Worldwide in the Magic of Disney

The Exhibition, which celebrates Disney 100 Years of Wonder, launches a World Tour at Philadelphia's Franklin Institute on February 18, 2023, with next stops announced,...

Drs. Jenn Conti, Heather Irobunda and Jennifer Lincoln launch Obstetricians for Reproductive Justice to share stories of harm happening in post-Roe America

Multicultural OBGYN advocates amplifying stories to keep reproductive justice in the forefront PORTLAND, Ore., Sept. 10, 2022 /PRNewswire/ --  It's been almost three months since...

NatraCure Donates 100% of Profits from New Chemotherapy Mitts in October and November

WHIPPANY, N.J., Sept. 9, 2022 /PRNewswire/ -- NatraCure, the manufacturer of cutting-edge health and wellness technologies, is introducing their new line of Chemotherapy products,...

New Drag, New Halo! VOOPOO DRAG New Products Released

SHENZHEN, China, Sept. 10, 2022 /PRNewswire/ -- On September 9th, VOOPOO unveiled two new products of DRAG series, DRAG H80S and DRAG E60. As...

STARKIST CO. HONORS KOREAN WAR VETERANS

Nearly 80 Korean War Veterans to Attend Reception that Honors Veterans of the Battle of Chosin Reservoir and are known as 'The Chosin Few' ARLINGTON,...

I-Mab Announces Positive Phase 2 Data of Lemzoparlimab in Combination with Azacitidine (AZA) in Patients with Higher Risk Myelodysplastic Syndrome at ESMO 2022

Lemzoparlimab combined with AZA showed encouraging clinical response in higher-risk MDS patientsFor patients received initial dose over 3 months, the ORR is 80.6% and...

All Traffic Solutions (ATS) Announces March 2022 ATS Gives Back Winner

All Traffic Solutions awarded a Shield 12 radar speed sign to the Belmont Police Department in New Hampshire through the company's ATS Gives Back...

CVC to CMS: Ongoing Cuts Undermine Healthcare Access and Quality Care

The CVC is stressing that ongoing cuts to office-based specialists under the Physician Fee Schedule are contributing to office-based center closures, health system consolidation,...
1...1,5061,5071,508...2,518Page 1,507 of 2,518

Latest articles